0001789835-23-000001.txt : 20230329
0001789835-23-000001.hdr.sgml : 20230329
20230329151702
ACCESSION NUMBER: 0001789835-23-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06c
FILED AS OF DATE: 20230329
DATE AS OF CHANGE: 20230329
EFFECTIVENESS DATE: 20230329
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Veravas, Inc.
CENTRAL INDEX KEY: 0001789835
IRS NUMBER: 822849414
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-477329
FILM NUMBER: 23774759
BUSINESS ADDRESS:
STREET 1: 128 COLUMBUS STREET, # 825
CITY: CHARLESTON
STATE: SC
ZIP: 29403
BUSINESS PHONE: 404-583-3513
MAIL ADDRESS:
STREET 1: 128 COLUMBUS STREET, # 825
CITY: CHARLESTON
STATE: SC
ZIP: 29403
D
1
primary_doc.xml
X0708
D
LIVE
0001789835
Veravas, Inc.
111 Congress Ave. Ste. 500
Austin
TX
TEXAS
78701
(512) 516-5228
DELAWARE
Sanguine Technologies, Inc.
None
Corporation
true
John
Forrest
111 Congress Ave., Ste. 500
Austin
TX
TEXAS
78701
Executive Officer
Chief Executive Officer
Other Health Care
Decline to Disclose
- 06c
false
2022-10-11
true
true
Royalty Interests
false
25000
50000000
775000
49225000
false
12
0
0
0
false
Veravas, Inc.
John Forrest
John Forrest
CEO
2023-03-29